EI
TEVA icon

Ethic Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Ethic Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Buy
20,171
+566
+3% +$18.9K 0.01% 830
2026
Q1 		$591K Buy
19,605
+1,478
+8% +$47.5K 0.01% 813
2025
Q4 		$566K Buy
18,127
+325
+2% +$8.01K 0.01% 812
2025
Q3 		$360K Sell
17,802
-688
-4% -$12.1K 0.01% 944
2025
Q2 		$310K Sell
18,490
-1,399
-7% -$22.6K 0.01% 973
2025
Q1 		$304K Sell
19,889
-35,434
-64% -$633K 0.01% 931
2024
Q4 		$1.22M Buy
55,323
+17,267
+45% +$314K 0.02% 545
2024
Q3 		$635K Sell
38,056
-6,320
-14% -$111K 0.02% 706
2024
Q2 		$721K Buy
44,376
+4,397
+11% +$67.7K 0.02% 661
2024
Q1 		$564K Buy
39,979
+28,748
+256% +$362K 0.01% 731
2023
Q4 		$117K Sell
11,231
-176
-2% -$1.64K ﹤0.01% 1014
2023
Q3 		$116K Buy
+11,407
New +$106K ﹤0.01% 975
2023
Q2 		– Sell
-14,446
Closed -$128K – 1016
2023
Q1 		$128K Buy
+14,446
New +$143K 0.01% 916
2022
Q4 		– Sell
-13,392
Closed -$108K – 930
2022
Q3 		$108K Buy
+13,392
New +$118K 0.01% 764

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Ethic Inc's TEVA Position: Q2 2026 in Review

Ethic Inc increased its Teva Pharmaceuticals (TEVA) stake by 2.9% in Q2 2026, buying an estimated $18.9K and bringing the position to 20,171 shares worth $683K. The position accounts for 0.01% of the portfolio, ranked #830.

Ethic Inc first reported a position in TEVA in Q3 2022 and has held it in 14 quarters since. The position peaked at $1.22M in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Ethic Inc held 20,171 shares of Teva Pharmaceuticals worth $683K as of Q2 2026.
  • Ethic Inc bought 566 Teva Pharmaceuticals shares in Q2 2026, an estimated $18.9K.
  • Teva Pharmaceuticals made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #830 holding.
  • Ethic Inc first reported a position in Teva Pharmaceuticals in Q3 2022 and has held it in 14 quarters since.
  • Ethic Inc's Teva Pharmaceuticals position peaked at $1.22M in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.